TEVA-EVEROLIMUS
TEVA CANADA LIMITED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of TEVA-EVEROLIMUS in Canada?
Yes. TEVA-EVEROLIMUS 2.5MG has an active shortage reported to Health Canada (last updated September 25, 2026).
Why is TEVA-EVEROLIMUS not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will TEVA-EVEROLIMUS be available again?
The manufacturer's estimated resolution date is August 10, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
AFINITOR
NOVARTIS PHARMACEUTICALS CANADA INC
SANDOZ EVEROLIMUS
SANDOZ CANADA INCORPORATED
Other Products
AFINITOR DISPERZ
NOVARTIS PHARMACEUTICALS CANADA INC
TEVA-EVEROLIMUS
TEVA CANADA LIMITED
CERTICAN
NOVARTIS PHARMACEUTICALS CANADA INC
REDDY-EVEROLIMUS
DR REDDY'S LABORATORIES LTD
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2027-08-10
~10 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02463229
Strength
2.5MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
EVEROLIMUS
Tier
Unrated
Last Updated
2026-09-25
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from TEVA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02143933
DIN 00834319
3.5MG · DIN 02438399
0.5MG · DIN 02301407
100MG · DIN 02420155
200MG · DIN 02420163
500MG · DIN 02247340
750MG · DIN 02247341
250MG · DIN 02247339
75MG · DIN 02303027
180MG · DIN 02370638
240MG · DIN 02370646